Sanofi moves ahead with CD&R deal for stake in consumer business

French pharmaceutical company Sanofi is proceeding with plans to sell U.S.-based private equity firm Clayton Dubilier & Rice a controlling stake in its consumer health busines Opella, which would be valued at around 16 billion euros, or about $17.3 billion, in the deal.